Investors

We value our investors immensely and are fortunate to have strategic investors who are committed in sharing our journey. We have true partnerships where we regularly meet to discuss our strategic direction, business plan and work together to overcome any hurdles that may come our way. We are always interested in working with other investors who can help us grow and who can lend their expertise to enable us to achieve our ambitious goals by working efficiently together.

Medisonal is funding our future plans!

In today’s dynamic healthcare landscape, innovation and technology are the cornerstones of global success. To harness these transformative forces and propel our healthcare business to new heights, we invite a diverse pool of investors to join us in this exciting journey.

Founder Message

Several years ago, I started to notice Cannabis-Based Products for Medicinal Use (CBPM) in the news. In one particular week towards the end of 2017, I heard it mentioned three times in as many conversations. It was then I realised I needed to look more closely into it.

At the time, I was recovering from a shoulder operation following a skiing accident and had been prescribed an opiate-based painkiller. It numbed the pain alright, but after experiencing some very unpleasant side effects, including drowsiness, I decided to stop taking them.

What I’d heard prompted me to try some CBPM instead, and this more natural approach gave me some relief, yet without the associated symptoms mentioned above. By comparison, the CBPM didn’t give me any side effects and I felt some relief in the constant throbbing of my shoulder.

This first-hand experience increased my interest, and I started having discussions with a new manufacturer who was about to embark on building a super high-tech, EU-GMP facility (now up and running). As I monitored developments in Germany and other EU countries, it became obvious that it was only a matter of time before the UK followed, so I decided to found Medisonal to help patients access medical cannabis.

In early 2018, several high-profile UK cases gave CBPM the exposure it needed. On 1 November 2018, some incredible lobbying of the UK government by parents of children affected by conditions known to be treatable with CBPM led, at last, to the reclassification of cannabis to schedule 2 of the Misuse of Drugs act of 1971. Despite this, over two years later, access to cannabis-based medicine in the UK remains a challenge.

Since 2017, I have been researching the UK market and seeking out the best management team to accompany me on my Medisonal journey. Today, I’m proud to have in place a core management and advisory team who are each ‘best-in-class’, experienced in their own field and bringing a unique skill set to the table.

Meanwhile, as I foresaw, developments are gaining momentum. These developments will see medical Cannabis shed its taboos and become as accepted as other plant-based remedies with incredible healing properties.

Medisonal Investors image

Investment Highlights

  • Proven track record of innovation: Our team has developed our proof of concept into a current healthcare solution that will significantly improve patient care. As soon as we receive our CQC registration, we are ready to go live. We have doctors and patients ready to go once we go live.
  • Strong market position: We are well-positioned in a rapidly growing market with significant unmet needs.
  • Experienced leadership team: Our leadership team brings deep expertise in healthcare, technology, and business development and well as banking and finance.
  • Commitment to social responsibility: We are dedicated to using our innovations to improve the lives of people around the world.

Your investment will fuel our ground-breaking initiatives, enabling us to

  • Pioneer cutting-edge healthcare solutions: We are committed to developing innovative healthcare technologies that address the most pressing medical challenges. Your investment will empower us to accelerate the development of these solutions, improving patient outcomes and transforming the healthcare industry.
  • Expand our global reach: With your support, we will expand our presence into new markets, bringing our innovative healthcare solutions to underserved communities worldwide. Your partnership will enable us to make a profound impact on global health.
  • Foster a collaborative ecosystem: We believe in the power of collaboration to drive innovation. Your investment will foster a vibrant ecosystem of partners, including researchers, clinicians, and industry experts, accelerating our progress towards groundbreaking healthcare solutions.

We seek investors who share our vision of a future where healthcare is accessible, affordable, and life-changing for all. Together, we can make a lasting impact on the world.

Our Team

Screenshot 2024-01-08 at 16.52.30

Lloyd Michaels

Founder

Screenshot 2024-01-08 at 17.10.00

Hana Salussolia

CEO

Dr. Anthony Ordman- Lead Clinician

Dr. Anthony Ordman

Lead clinician

 
Screenshot 2024-01-08 at 17.29.35

Katrina Boulton

Lead Nurse

Screenshot 2024-01-08 at 17.38.05

Carl Woolf

Pharmaceutical Director

Laurence Hansen- Scientific Advisor

Laurence Hansen

Scientific Advisor

Thomas Levene- Digital Projects lead

Thomas Levene

Digital Projects Lead

Andrew Case- Legal Counsel

Andrew Case

Legal Counsel

Our Advisors

Screenshot 2024-01-08 at 17.53.40

Donald Featherstone

Non-Executive Director

1662485021289

Jane Karczewski

Non-Executive Director

Screenshot 2024-01-08 at 17.54.19

Nick Davis

Legal Advisor

Screenshot 2024-01-08 at 17.56.03

Dr. Nathan Hasson

M.B, Ch.B., M.R.C.P., F.R.C.P.C.H
Medical Advisor

Screenshot 2024-01-08 at 17.57.06

Dr. Karolina Afors

Medical Advisor

Screenshot 2024-01-08 at 17.55.44

Dr. Amelia Seifalian

Medical Advisor

 
Screenshot 2024-01-08 at 17.57.50

Dr. Carlos Cobiella

LMS FRCS Ed (Tr & Orth)
Medical Advisor

Our Partners

Join us in shaping the future of healthcare

By investing in our healthcare technology business, you are not only making a sound financial decision but also investing in a healthier and more equitable future for all. Together, we can revolutionise healthcare and make a lasting impact on the world.

Scroll to Top